NRX-201

Exhibitor

Area of exhibition:

Stand

Knowledge-generating body:

Servatrix Biomed S.L. originates from the Autonomous University of Madrid (UAM), where its core scientific knowledge and technology were generated through long-term academic research in biomedical sciences, particularly in the NRF2 pathway and chronic liver disease.

Servatrix Biomed S.L.’s prototype/product is a proprietary NRF2-activating lead compound, currently in preclinical development, designed for the treatment of MASH/NASH.

Country:

Spain

Region:

Community of Madrid

Sectors:

Industrial Biotech

Chemicals

SDG:

SDG03: Good health and well-being

Video Link:

View video here

Applications

The prototype/product developed by Servatrix Biomed S.L. is intended to be used as a prescription therapeutic drug for patients with MASH/NASH, with the practical application of reducing liver fat, inflammation, and oxidative stress to slow or halt disease progression and prevent severe outcomes such as fibrosis, cirrhosis, and liver failure.

Medical Devices

Industrial Biotech

Exhibitor

false

OncoGuard Liquid Biopsy

Region

Romania

Health

Medical Devices

Food & Agro

Other

Environment & Water

Exhibitor

false

LAB-ON-COFFEE

Region

Navarre

Spain

Industrial Biotech

Exhibitor

false

Biological Material – Blautia massiliensis ABL231

Region

Valencian Community

Spain